Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis

Tuberculosis is a leading cause of death in our country. Multidrug-resistant tuberculosis increases the morbidity and mortality due to severe manifestations and difficult and prolonged medications. Newer antitubercular drugs like delamanid have been approved by WHO in management of these cases, but...

Full description

Bibliographic Details
Main Authors: Vikas Marwah, Prashant R Patil, Robin Choudhary, Virender Malik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Lung India
Subjects:
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=1;spage=75;epage=78;aulast=Marwah
_version_ 1797954785793540096
author Vikas Marwah
Prashant R Patil
Robin Choudhary
Virender Malik
author_facet Vikas Marwah
Prashant R Patil
Robin Choudhary
Virender Malik
author_sort Vikas Marwah
collection DOAJ
description Tuberculosis is a leading cause of death in our country. Multidrug-resistant tuberculosis increases the morbidity and mortality due to severe manifestations and difficult and prolonged medications. Newer antitubercular drugs like delamanid have been approved by WHO in management of these cases, but the real-world experience of this drug is lacking in our country. We present our early experience of use of delamanid in extensively drug-resistant pulmonary tuberculosis.
first_indexed 2024-04-10T23:22:58Z
format Article
id doaj.art-43887f2722f04aa182c92f2810e72b4d
institution Directory Open Access Journal
issn 0970-2113
0974-598X
language English
last_indexed 2024-04-10T23:22:58Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Lung India
spelling doaj.art-43887f2722f04aa182c92f2810e72b4d2023-01-12T13:28:37ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2023-01-01401757810.4103/lungindia.lungindia_451_22Early experience of delamanid in extensively drug-resistant pulmonary tuberculosisVikas MarwahPrashant R PatilRobin ChoudharyVirender MalikTuberculosis is a leading cause of death in our country. Multidrug-resistant tuberculosis increases the morbidity and mortality due to severe manifestations and difficult and prolonged medications. Newer antitubercular drugs like delamanid have been approved by WHO in management of these cases, but the real-world experience of this drug is lacking in our country. We present our early experience of use of delamanid in extensively drug-resistant pulmonary tuberculosis.http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=1;spage=75;epage=78;aulast=Marwahdelamanidextensively drug-resistant tuberculosissputum smear positive pulmonary tuberculosis
spellingShingle Vikas Marwah
Prashant R Patil
Robin Choudhary
Virender Malik
Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
Lung India
delamanid
extensively drug-resistant tuberculosis
sputum smear positive pulmonary tuberculosis
title Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
title_full Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
title_fullStr Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
title_full_unstemmed Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
title_short Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
title_sort early experience of delamanid in extensively drug resistant pulmonary tuberculosis
topic delamanid
extensively drug-resistant tuberculosis
sputum smear positive pulmonary tuberculosis
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=1;spage=75;epage=78;aulast=Marwah
work_keys_str_mv AT vikasmarwah earlyexperienceofdelamanidinextensivelydrugresistantpulmonarytuberculosis
AT prashantrpatil earlyexperienceofdelamanidinextensivelydrugresistantpulmonarytuberculosis
AT robinchoudhary earlyexperienceofdelamanidinextensivelydrugresistantpulmonarytuberculosis
AT virendermalik earlyexperienceofdelamanidinextensivelydrugresistantpulmonarytuberculosis